[ORGANIZATION]
IKS014
Featured in 1 tracked story · first seen
Also covered in
-
LigaChem Bio partner Iksuda reports 50% ORR for IKS014 in breast cancer
[HEALTH] · 2 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[HEALTH] · 2 sources ·